Skip to main content
SpringerLink
Log in

Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment

  • Drug Interactions
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Intravenous nicardipine, 5 mg, was administered in two comparable groups of eight patients with chronic coronary artery disease but no clinical signs of heart failure. One group had received no previous treatment and served as a control group, and the other had received long-term treatment with large oral doses of propranolol. Blood concentrations of nicardipine were higher, and the area under the plasma concentration curve was greater in the group previously treated by propranolol. The total clearance of nicardipine was decreased in patients taking propranolol, without a change in the half-life of the drug. Typical hemodynamic responses, namely, a decrease in aortic pressure and in arterial resistances, were greater and more lasting in patients previously treated orally by propranolol. Filling pressure remained stable in both groups. The nicardipine infusion did not induce signs of dromotropic or inotropic negative effects in either group. The greater and more lasting hemodynamic effects of nicardipine in the group previously treated orally by propranolol do not seem to be related to an overall hemodynamic action of propranolol, but are probably due to higher nicardipine plasma levels, and may be caused by a decrease in hepatic blood flow induced by propranolol, with a consequent decrease in nicardipine clearance and by a smaller nicardipine volume of distribution in the propranolol group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ryden L, Saetre H. The haemodynamic effect of verapamil.Eur J Clin Pharmacol 1971:3:153–157.

    Google Scholar 

  2. Atterhög JH, Ekelund LG, Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men.Eur J Clin Pharmacol 1975; 8:317–322.

    PubMed  Google Scholar 

  3. Robson RH, Wishwanath MC, Nifedipine and beta blockade as a cause of cardiac failure.Br Med J 1982;294:104.

    Google Scholar 

  4. Opie LH, White DA, Adverse interaction between nifedipine and beta blockade.Br Med J 1980;281:1462.

    PubMed  Google Scholar 

  5. Rousseau MF, Etienne J, Van Mechelen H, et al. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease.J Cardiorase Pharmacol 1984;6:833–839.

    Google Scholar 

  6. Rocha P, Zannier D, Baron B, et al. Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.Am J Cardiol 1987;59:775–781.

    PubMed  Google Scholar 

  7. Leon M, Rosing D, Bonow R, et al. Combination therapy with calcium-channel blockers and beta-blockers for chronic stable angina pectoris.Am J Cardiol 1985;55:69B-80B.

    PubMed  Google Scholar 

  8. Dow RJ, Graham DJM. A review of the human metabolism and pharmacokinetics of nicardipine hydrochloride.Br J Clin Pharmacol 1986:22:195S-202S.

    Google Scholar 

  9. Parker G, Danheshmed TK, Roberts JC. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?J Clin Pharmacol 1984;24:493–499.

    PubMed  Google Scholar 

  10. Dodge HT, Determination of left ventricular volume and mass.Radiol Clin North Am 1971;9:459–467.

    PubMed  Google Scholar 

  11. Grunk-Emeier GL, Burg BA, Anderson RP, A simple method for calculating Vmax.Clin Res 1973;31:422.

    Google Scholar 

  12. Wu A, Massey I, Kushinsky S, Capillary column gas chromatographic method using electron capture detection for the simultaneous determination of nicardipine and its pyridine metabolite in plasma.J Chromatog 1987;415:65–73.

    Google Scholar 

  13. Gomeni R. PHARM. An interactive program for individual and population pharmacokinetic parameter estimation.Comput Biol Med 1984;14:25–34.

    PubMed  Google Scholar 

  14. Perrier D, Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration.J Pharm Sci 1982;71:372–373.

    PubMed  Google Scholar 

  15. Pang KS, Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J Pharmacokin Biopharm 1977;5:625–653.

    Google Scholar 

  16. Gibson DG. Pharmacodynamic properties of β-adrenergic receptor blocking drugs in man.Drugs 1974;7:8–38

    PubMed  Google Scholar 

  17. Kleinbloesem CH. Van Brummelen P, Sandberg TWH, et al. Kinetic and hemodynamic interactions between nifedipine and propranolol in healthy subjects utilizing controlled rates of drug input. In: Nifedipine, clinical pharmacokinetics and hemodynamic effects, PhD. Thesis, Gravenhage Netherlands, pp. 151–166.

  18. Kendall MJ, Jack DB, Laugher SJ, et al. Lack of a pharmacokinetic interaction between nifedipine and the β-adrenoceptor blockers, metoprolol and atenolol.Br J Clin Pharmacol 1984:18:331–335.

    PubMed  Google Scholar 

  19. Epstein SE, Branwald E, Beta-adrenergic receptor blocking drugs: Mechanism of action and clinical applications.N Engl J Med 1966:275:1106.

    PubMed  Google Scholar 

  20. Ulrich M, Frochlich ED, Dustan AP, et al. Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive man.Circulation 1968;37:411–416.

    PubMed  Google Scholar 

  21. Tarazi RC, Dustan HP, Beta-adrenergic blockade in hypertension.Am J Cardiol 1972;29:633–640.

    PubMed  Google Scholar 

  22. Tarazi RC, Dustan HP, Bravo EL, Haemodynamic effects of propranolol in hypertension: A review.Postgrad Med J 1976;52(Suppl 4):92–100.

    Google Scholar 

  23. Lambert CR, Hill JA, Feldman RL, et al. Effects of nicarlipine on left ventricular function and energetics in man.Int J Cardiol 1986;10:237–249.

    PubMed  Google Scholar 

  24. Berland J, Savin T, Cribier A, et al. Effects of low dose nicardipine on systemic and coronary hemodynamics during rapid atrial pacing in patients with ischemic heart disease.J Am Coll Cardiol 1986;7:179A.

    Google Scholar 

  25. Winniford MD, Markham RV, Firth BG, et al. Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.Am J. Cardiol 1982:50:704–710.

    PubMed  Google Scholar 

  26. Hung J, Lamb IH, Conally SJ, et al.. The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: A double-blind randomized, and placebo-controlled study.Circulation 1983;68:560–567.

    PubMed  Google Scholar 

  27. Rocha P, Baron B, Delestrain A, et al. Hemodynamic effects of intravenous diltiazem in patients treated chronically with propranolol.Am Heart J 1986;111:62–68.

    PubMed  Google Scholar 

  28. Rowland E, Razis P, Sugrue D, et al. Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.Br Heart J 1983:50:383–389.

    PubMed  Google Scholar 

  29. Packer M, Meller J, Medina N, et al. Hemodynamic consequences of combined beta-adrenergic and slow calcium-channel blockade in man.Circulation 1982;65:660–668.

    PubMed  Google Scholar 

  30. Oesterle SN, Alderman EL, Beier-Scott L, et al. Diltiazem and propranolol combination: Hemodynamic effects following acute intravenous administration.Am Heart J 1986; 111:489–497.

    PubMed  Google Scholar 

  31. Josh PI, Dalal JJ, Ruttley MSJ, et al. Nifedipine and left ventricular function in beta-blocked patients.Br Heart J 1981;45:457–459.

    PubMed  Google Scholar 

  32. Visioli O, Bolognesi R, Cucchini F, et al. The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.Cardiocase Drugs Ther 1987;1:353–358.

    Google Scholar 

Download references

Author information

Author notes

  1. P. Rocha

    Present address: Department of Cardiology, Centre Hospitalier Intercommunal, 10, rue du Champ Gaillard, 78303, Poissy, France

Authors and Affiliations

  1. Department of Cardiology, Centre Hospitalier Intercommunal, 10, rue du Champ Gaillard, 78303, Poissy, France

    X. Marchand & J. C. Kahn

  2. Sandoz Laboratories, Rueil-Malmaison, France

    M. Guerret & D. David

Authors
  1. P. Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Guerret
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. David
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. Marchand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. C. Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rocha, P., Guerret, M., David, D. et al. Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment. Cardiovasc Drug Ther 4, 1525–1532 (1990). https://doi.org/10.1007/BF02026502

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02026502

Key Words

Search

Navigation